Senior Manager, Regional Access, Germany
The Opportunity:
In this role you will drive the execution of regional and local market access priorities within the national market access strategy, identifying and prioritizing barriers to timely and sustainable patient access. The role will be responsible for providing hands-on support in executing key launch activities across Germany supporting country-level regional and local market access tactics and initiatives to secure reimbursement of Revolution Medicines’ assets. In close cooperation with the sales, marketing, government affairs, and medical departments and in line with the overall commercial business strategy, you will have an instrumental role in the development and execution of market access solutions. This will involve detailed and strategic involvement of various internal and external stakeholders, including hospitals, office-based oncologists, pharmacies, health insurances as well as medical associations and policy makers.
Key Responsibilities:
Secure listing in hospital pharmacy lists for Revolution Medicines’ assets once available across Germany, identifying organizational hurdles that might hinder broad adaptation in existing treatment algorithms.
Identify market specific needs of prescribers, pharmaceutical decision makers and health policy stakeholders and develop tactics to address evolving market access barriers.
Identify access barriers and developing/recommending regional or local approaches and tactics within the established market-access strategy to enable patient-access. This may include e.g. named-patient access, if needed, complying with all relevant regulations for industry involvement.
Establish and maintain a network amongst opinion leaders, health insurances, physicians’ associations, and health policy makers.
Serve as one of the primary contact points for various market access stakeholder groups, including health insurances (incl. MDK), pharmacies, and hospital administrators.
Monitor, collect and inform internal stakeholders with insights on emerging changes in the pharmaceutical policy, pricing, and market access reimbursement framework relevant in the context of Revolution Medicines’ assets. Translate regional insights into actionable recommendations for the regional and national market access team to inform launch and lifecycle planning.
Position and represent Revolution Medicines and its assets in the best possible way towards all relevant healthcare bodies and stakeholders in Germany.
Jointly with the Regional Access team initiate and organize regional/local events and projects to support reimbursement activities. Provide internal and external explanations and training materials regarding market access topics for all relevant stakeholder groups.
Partner with Sales, Medical and other relevant functions to address regional patient-access barriers, taking ownership of agreed access-related initiatives and providing expertise on reimbursement matters, including but not limited to: supportive argumentation on the value of the innovative character of Revolution Medicines assets, participating in discussions with German oncologists on reimbursement and market access topics, supporting initiatives around NUB applications for hospital use of Revolution Medicines assets in Germany.
Required Skills, Experience and Education:
Bachelor’s degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA).
6+ years of experience in a Regional Market Access role within the pharmaceutical or biopharma industry.
Extensive experience in working with statutory health insurance companies in Germany, as well as with physicians’ associations, MDK (“Medizinischer Dienst”), and other stakeholders.
Extensive knowledge of existing regulations in the German pharmaceutical healthcare system, including but not limited to the legal pricing framework, post-AMNOG system-imminent access hurdles, dispensing of pharmaceuticals, the taxation and reimbursement framework, (re-) importation of pharmaceuticals, patient-individual importation of drugs, federal/regional contracts on dispensation of pharmaceuticals (e.g. dispensing quotas, “Praxisbesonderheiten”).
Proven successful interaction with relevant stakeholders within the self-governing bodies in Germany.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
#LI-LO1 #LI-Remote